Transforming growth factor-β1 (TGF-β)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-β-activated kinase 1 and mitogen-activated protein kinase kinase 3

Molecular Biology of the Cell

Volumn 14, Issue 2, 2003, Pages 529-544

  Edlund, Sofia ^a,c   Bu, Shizhong ^a,c   Schuster, Norbert ^a   Aspenström, Pontus ^a   Heuchel, Rainer ^a   Heldin, Nils Erik ^b   Ten Dijke, Peter ^b   Heldin, Carl Henrik ^a   Landström, Maréne ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHOTRANSFERASE; SMAD7 PROTEIN; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL INTERACTION; CELL TYPE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INCUBATION TIME; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; COS CELLS; DNA FRAGMENTATION; DNA-BINDING PROTEINS; ENZYME ACTIVATION; ENZYME INHIBITORS; GENES, DOMINANT; HUMANS; IN SITU NICK-END LABELING; MALE; MAP KINASE KINASE 3; MAP KINASE KINASE KINASES; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PRECIPITIN TESTS; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; SMAD7 PROTEIN; TIME FACTORS; TRANS-ACTIVATORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

EID: 0037326526     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.02-03-0037     Document Type: Article

References (65)

1. Adachi-Yamada, T., Nakamura, M., Irie, K., Tomoyasu, Y., Sano, Y., Mori, E., Goto, S., Ueno, N., Nishida, Y., and Matsumoto, K. (1999). p38 mitogen-activated protein kinase can be involved in transforming growth factor-β superfamily signal transduction in Drosophila wing morphogenesis. Mol. Cell. Biol. 19, 2322-2329.
2. Afrakhte, M., Morén, A., Jossan, S., Itoh, S., Sampath, K., Westermark, B., Heldin, C.-H., Heldin, N.-E., and ten Dijke, P. (1998), Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members. Biochem. Biophys. Res. Commun. 249, 505-511.
3. Atfi, A., Buisine, M., Mazars, A., and Gespach, C. (1997a). Induction of apoptosis by DPC4, a transcriptional factor regulated by transforming growth factor-β through stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signaling pathway. J. Biol. Chem. 272, 24731-24734.
4. Atfi, A., Djelloul, S., Chastre, E., Davis, R., and Gespach, C. (1997b). Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor β-mediated signaling. J. Biol. Chem. 272, 1429-1432.
5. Attisano, L., and Wrana, J.L. (2000). Smads as transcriptional co-modulators. Curr. Opin. Cell Biol. 12, 235-243.
6. Bai, S., and Cao, X. (2002). A nuclear antagonistic mechanism of inhibitorv Smads in transforming growth factor-β signaling. J. Biol. Chem. 277, 4176-4182.
7. Bai, S., Shi, X., Yang, X., and Cao, X. (2000). Smad6 as a transcriptional corepressor. J. Biol. Chem. 275, 8267-8270.
8. Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A.A., Rojkind, M., and Bottinger, E.P. (2000). A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA. Genes Dev. 14, 187-197.
9. Chang, L., and Karin, M. (2001). Mammalian MAP kinase signaling cascades. Nature 410, 37-40.
10. Cowley, S., Paterson, H., Kemp, P., and Marshall, C.J. (1994). Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77, 841-852.
11. Cuenda, A., Rouse, J., Doza, Y.N., Meier, R., Cohen, P., Gallagher, T.F., Young, P.R., and Lee, J.C. (1995). SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364, 229-233.
12. Davis, R.J. (2000). Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
13. Ebisawa, T., Fukuchi, M., Murakami, G., Chiba, T., Tanaka, K., Imamura, T., and Miyazono, K. (2001). Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem. 276, 12477-12480.
14. Edlund, S., Landström, M., Heldin, C.-H., and Aspenström, P. (2002). Transforming growth factor-β-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol. Biol. Cell 13, 902-914.
15. Engel, M.E., McDonnell, M.A., Law, B.K., and Moses, H.L. (1999). Interdependent SMAD and JNK signaling in transforming growth factor-β-mediated transcription. J. Biol. Chem. 274, 37413-37420.
16. Eyers, P.A., Craxton, M., Morrice, N., Cohen, P., and Goedert, M. (1998). Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution. Chem. Biol. 5, 321-328.
17. Franzén, P., Ichijo, H., and Miyazono, K. (1993). Different signals mediate transforming growth factor-β1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells. Exp. Cell Res. 207, 1-7.
18. Gupta, S., Campbell, D., Derijard, B., and Davis, R.J. (1995). Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267, 389-393.
19. Han, J., Lee, J.D., Bibbs, L., and Ulevitch, R.J. (1994). A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265, 808-811.
20. Hanafusa, H., Ninomiya-Tsuji, J., Masuyama, N., Nishita, M., Fujisawa, J., Shibuya, H., Matsumoto, K., and Nishida, E. (1999). Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-β-induced gene expression. J. Biol. Chem. 274, 27161-27167.
21. Hanyu, A., Ishidou, Y., Ebisawa, T., Shimanuki, T., Imamura, T., and Miyazono, K. (2001). The N domain of Smad7 is essential for specific inhibition of transforming growth factor-β signaling. J. Cell Biol. 155, 1017-1027.
22. Hayashi, H., et al., (1997). The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89, 1165-1173.
23. Heldin, C.-H., Miyazono, K., and ten Dijke, P. (1997). TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
24. Hocevar, B.A., Brown, T.L., and Howe, P.H. (1999). TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18, 1345-1356.
25. Hsu, S.C., Gavrilin, M.A., Tsai, M.H., Han, J., and Lai, M.Z. (1999). p38 mitogen-activated protein kinase is involved in Fas ligand expression. J. Biol. Chem. 274, 25769-25776.
26. Hu, P.P., Shen, X., Huang, D., Liu, Y., Counter, C., and Wang, X.F. (1999). The MEK pathway is required for stimulation of p21(WAF1/CIP1) by transforming growth factor-β. J. Biol. Chem. 274, 35381-35387.
27. Ichijo, H., Nishida, E., Irie, K., ten Dijke, P., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K., and Gotoh, Y. (1997). Induction of apoptosis by A.S.K1, a mammalian M.A.P.K.K.K. that activates S.A.P.K/J.N.K. and p38 signaling pathways. Science 275, 90-94.
28. Imamura, T., Takase, M., Nishihara, A., Oeda, E., Hanai, J., Kawabata, M., and Miyazono, K. (1997). Smad6 inhibits signaling by the TGF-β superfamily. Nature 389, 622-626.
29. Itoh, S., Landström, M., Hermansson, A., Itoh, F., Heldin, C.-H., Heldin, N.-E., and ten Dijke, P. (1998). Transforming growth factor β1 induces nuclear export of inhibitory Smad7. J. Biol. Chem. 273, 29195-29201.
30. Jiang, Y., Chen, C., Li, Z., Guo, W., Gegner, J.A., Lin, S., and Han, J. (1996). Characterization of the structure and function of a new mitogen-activated protein kinase (p38β). J. Biol. Chem. 271, 17920-17926.
31. Kavsak, P., Rasmussen, R.K., Causing, C.G., Bonni, S., Zhu, H., Thomsen, G.H., and Wrana, J.L. (2000). Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation. Mol. Cell 6, 1365-1375.
32. Kimura, N., Matsuo, R., Shibuya, H., Nakashima, K., and Taga, T. (2000). BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J. Biol. Chem. 275, 17647-17652.
33. Kretzschmar, M., Doody, J., and Massagué, J. (1997). Opposing BMP and EGF signaling pathways converge on the TGF-β family mediator Smad1. Nature 389, 618-622.
34. Kummer, J.L., Rao, P.K., and Heidenreich, K.A. (1997). Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 272, 20490-20494.
35. Lallemand, F., Mazars, A., Prunier, C., Bertrand, F., Kornprost, M., Gallea, S., Roman-Roman, S., Cherqui, G., and Atfi, A. (2001). Smad7 inhibits the survival nuclear factor κB and potentiates apoptosis in epithelial cells. Oncogene 20, 879-884.
36. Landström, M., Heldin, N.-E., Bu, S., Hermansson, A., Itoh, S., ten Dijke, P., and Heldin, C.-H. (2000). Smad7 mediates apoptosis induced by transforming growth factor β in prostatic carcinoma cells. Curr. Biol. 10, 535-538.
37. Lee, J.C., et al. (1994). A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746.
38. Livingstone, C., Patel, G., and Jones, N. (1995). ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J. 14, 1785-1797.
39. Massagué, J. (2000). How cells read TGF-β signals. Nat. Rev. Mol. Cell. Biol. 1, 169-178.
40. Mazars, A., Lallemand, F., Prunier, C., Marais, J., Ferrand, N., Pessah, M., Cherqui, G., and Atfi, A. (2001). Evidence for a role of the JNK cascade in Smad7-mediated apoptosis. J. Biol. Chem. 276, 36797-36803.
41. Miyazono, K., ten Dijke, P., and Heldin, C.-H. (2000). TGF-β signaling by Smad proteins. Adv. Immunol. 75, 115-157.
42. Nakao, A., et al. (1997). Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signaling. Nature 389, 631-635.
43. Nebreda, A.R., and Porras, A. (2000). p38 MAP kinases, beyond the stress response. Trends Biochem. Sci. 25, 257-260.
44. Pulaski, L., Landström, M., Heldin, C.-H., and Souchelnytskyi, S. (2001). Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-β-dependent signaling but affects Smad7-dependent transcriptional activation. J. Biol. Chem. 276, 14344-14349.
45. Pyrzynska, B., Mosieniak, G., and Kaminska, B. (2000). Changes of the trans-activating potential of AP-1 transcription factor during cyclosporin A-induced apoptosis of glioma cells are mediated by phosphorylation and alterations of AP-1 composition. J. Neurochem. 74, 42-51.
46. Sano, Y., Harada, J., Tashiro, S., Gotoh-Mandeville, R., Maekawa, T., and Ishii, S. (1999). ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-β signaling. J. Biol. Chem. 274, 8949-8957.
47. Schiffer, M., Bitzer, M., Roberts, I.S., Kopp, J.B., ten Dijke, P., Mundel, P., and Böttinger, E.P. (2001). Apoptosis in podocytes induced by TGF-β and Smad7. J. Clin. Invest. 108, 807-816.
48. Shibuya, H., Iwata, H., Masuyama, N., Gotoh, Y., Yamaguchi, K., Irie, K., Matsumoto, K., Nishida, E., and Ueno, N. (1998). Role of TAK1 and TAB1 in BMP signaling in early Xenopus development. EMBO J. 17, 1019-1028.
49. Shibuya, H., Yamaguchi, K., Shirakabe, K., Tonegawa, A., Gotoh, Y., Ueno, N., Irie, K., Nishida, E., and Matsumoto, K. (1996). TAB1: an activator of the TAK1 MAPKKK in TGF-β signal transduction. Science 272, 1179-1182.
50. Shin, I., Bakin, A.V., Rodeck, U., Brunet, A., and Arteaga, C.L. (2001). Transforming growth factor β enhances epithelial cell survival via Akt-dependent regulation of FKHRL1. Mol. Biol. Cell 12, 3328-3339.
51. Schrantz, N., Bourgeade, M.F., Mouhamad, S., Leca, G., Sharma, S., and Vazquez, A. (2001). p38-mediated regulation of an Fas-associated death domain protein-independent pathway leading to caspase-8 activation during TGFβ-induced apoptosis in human Burkitt lymphoma B cells BL41. Mol. Biol. Cell. 12, 3139-3151. 0
52. Takatsu, Y., Nakamura, M., Stapleton, M., Danos, M.C., Matsumoto, K., O'Connor, M.B., Shibuya, H., and Ueno, N. (2000). TAK1 participates in c-Jun N-terminal kinase signaling during Drosophila development. Mol. Cell. Biol. 20, 3015-3026.
53. Ulloa, L., Doody, J., and Massagu, J. (1999). Inhibition of transforming growth factor-β/SMAD signaling by the interferon-gamma/STAT pathway. Nature 397, 710-713.
54. van Dam, H., Wilhelm, D., Herr, I., Steffen, A., Herrlich, P., and Angel, P. (1995). ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 14, 1798-1811.
55. Walton, M., Woodgate, A.M., Sirimanne, E., Gluckman, P., and Dragunow, M. (1998). ATF-2 phosphorylation in apoptotic neuronal death. Brain Res. Mol. Brain Res. 63, 198-204.
56. Wang, W., Zhou, G., Hu, M.C.-T., Yao, Z., and Tan, T.-H. (1997). Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor β (TGF-β)-activated kinase (TAK1), a kinase mediator of TGF β signal transduction. J. Biol. Chem. 272, 22771-22775.
57. Watanabe, H., de Caestecker, M.P., and Yamada, Y. (2001). Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-β-induced aggrecan gene expression in chondrogenic ATDC5 cells. J. Biol. Chem. 276, 14466-14473.
58. Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J., and Greenberg, M.E. (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331.
59. Yamagishi, S., Yamada, M., Ishikawa, Y., Matsumoto, T., Ikeuchi, T., and Hatanaka, H. (2001). p38 mitogen-activated protein kinase regulates low potassium-induced c-Jun phosphorylation, and apoptosis in cultured cerebellar granule neurons. J. Biol. Chem. 276, 5129-5133.
60. Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., and Matsumoto, K. (1995). Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270, 2008-2011.
61. Yanagisawa, M., Nakashima, K., Takeda, K., Ochiai, W., Takizawa, T., Ueno, M., Takizawa, M., Shibuya, H., and Taga, T. (2001). Inhibition of BMP2-induced, TAK1 kinase-mediated neurite outgrowth by Smad6 and Smad7. Genes Cells 6, 1091-1099.
62. Young, P.R., et al. (1997). Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J. Biol. Chem. 272, 12116-12121.
63. Yue, J., and Mulder, K.M. (2000). Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor β1 production in a Smad-dependent pathway. J. Biol. Chem. 275, 30765-30773.
64. Zhang, Y., and Derynck, R. (2000). Transcriptional regulation of the transforming growth factor-β-inducible mouse germ line Ig α constant region gene by functional cooperation of Smad, CREB and AML family members. J. Biol. Chem. 275, 16979-16985.
65. Zhang, Y., Feng, X.H., and Derynck, R. (1998). Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature 394, 909-913.